E. C, “PREVALANE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, J ASEAN Fed Endocr Soc, vol. 34, p. 21, Jul. 2019.